Skip Nav Destination
1-5 of 5
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Demethylating Agents Reprogram Myelodysplastic Syndrome and Leukemia Cells, Sensitizing Them To Poly-(ADP)-Ribose Polymerase Inhibitors
Carine Robert, PhD, Nidal E Muvarak, MS, Vu H. Duong, MD, Maria R. Baer, MD, Stephen B. Baylin, MD, Feyruz Rassool, PhD
Blood (2013) 122 (21): 3778.
Blood (2010) 116 (21): SCI-28.
Changes in Promoter Methylation and Gene Expression in Patients with MDS and MDS-AML Treated with 5-Azacitidine and Sodium Phenylbutyrate.
Steven D. Gore, MD, Stephen B. Baylin, MD, Tianna Dauses, RN, Michael R. Grever, MD, Anchalee Jiemjit, MS, Jasper Manning, MS, Carole B. Miller, MD, Anthony J. Murgo, MD, James A. Zwiebel, MD, James G. Herman, MD
Blood (2004) 104 (11): 469.
p15 INK4B CpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional Silencing
Blood (1999) 94 (7): 2445–2451.
Blood (1999) 93 (12): 4347–4353.